Ian Okazaki

Title: Ian Okazaki: Innovator in Molecular Characterization

Introduction

Ian Okazaki is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of molecular biology, particularly in the characterization of NAD:arginine ADP-ribosyltransferases. His work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Ian Okazaki holds a patent for his invention titled "Mammalian muscle NAD: arginine ADP-ribosyltransferase." This invention relates to the identification and molecular characterization of NAD:arginine ADP-ribosyltransferases. The patent provides sequences from both rabbit skeletal muscle and human NAD:arginine ADP-ribosyltransferase. Additionally, it describes the expression of recombinant protein from a recombinant gene vector containing at least 15 continuous bases of genes encoding these sequences. He has 1 patent to his name.

Career Highlights

Ian Okazaki works for the United States of America as represented by the Department of Health. His role involves research and development in the field of molecular biology, where he applies his expertise to advance scientific knowledge and innovation.

Collaborations

Ian has collaborated with esteemed colleagues such as Joel Moss and Anna Zolkiewska. These collaborations have enriched his research and contributed to the advancement of their shared scientific goals.

Conclusion

Ian Okazaki is a distinguished inventor whose work in molecular characterization has the potential to impact various fields. His contributions to the understanding of NAD:arginine ADP-ribosyltransferases highlight the importance of innovation in scientific research.